Medicare Enrolled

Dr. Zarine Ter-Poghosyan, M.D.

Family Medicine · Burbank, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
303 S GLENOAKS BLVD, Burbank, CA 91502
8188428400
In practice since 2007 (18 years)
NPI: 1114102993 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ter-Poghosyan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ter-Poghosyan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ter-Poghosyan

Dr. Zarine Ter-Poghosyan is a family medicine specialist in Burbank, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ter-Poghosyan performed 20,461 Medicare services across 3,003 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ter-Poghosyan received a total of $23,779 from 72 pharmaceutical and/or device companies across 1110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ter-Poghosyan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 0% volume in CA $23,779 industry payments

Medicare Practice Summary

Medicare Utilization ↗
20,461
Medicare services
Top 0% in CA for family medicine
3,003
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,137 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
11,935 $5 $6
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,978 $70 $136
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,837 $8 $15
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
1,766 $1 $9
Blood glucose level test
A test that measures the amount of sugar in your blood.
752 $4 $7
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
448 $44 $82
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
395 $42 $149
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
245 $12 $57
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
233 $88 $180
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
153 $64 $197
Home health agency supervision, complex multidisciplinary care
Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision.
84 $83 $159
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
83 $11 $75
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
81 $1 $15
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
78 $120 $279
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
46 $28 $150
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
45 $11 $100
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
45 $1 $20
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
44 $23 $59
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
44 $8 $50
Smoking cessation counseling, more than 10 minutes
Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes.
38 $29 $50
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
32 $69 $179
Obesity behavioral counseling, 15 minutes
A 15-minute face-to-face session focused on behavioral counseling to help manage obesity.
31 $27 $46
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
20 $32 $49
Influenza vaccine, quadrivalent, 0.5 ml dosage 19 $20 $44
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
16 $41 $150
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
13 $101 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
71.0% medium
28.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$23,779
Total received (2018-2024)
Avg $3,397/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,110
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,366 (94.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,288 (5.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$124 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,995
2023
$3,486
2022
$2,172
2021
$4,426
2020
$2,450
2019
$4,332
2018
$3,918

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$648
ABBVIE INC.
$438
AstraZeneca Pharmaceuticals LP
$320
Lilly USA, LLC
$211
Otsuka America Pharmaceutical, Inc.
$182
Bayer Healthcare Pharmaceuticals Inc.
$163
Novartis Pharmaceuticals Corporation
$138
Sumitomo Pharma America, Inc.
$132
GlaxoSmithKline, LLC.
$100
Novo Nordisk Inc
$87
Almatica Pharma LLC
$73
Takeda Pharmaceuticals U.S.A., Inc.
$66
PFIZER INC.
$56
IRONWOOD PHARMACEUTICALS, INC
$52
Phathom Pharmaceuticals, Inc.
$51
Digestive Care, Inc.
$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$48
GENZYME CORPORATION
$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Radius Health, Inc.
$27
VIVUS LLC
$23
Mylan Specialty L.P.
$22
SCILEX PHARMACEUTICALS INC.
$20
Exact Sciences Corporation
$14
Top 3 companies account for 47.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,064
AstraZeneca Pharmaceuticals LP
$1,436
Biohaven Pharmaceuticals, Inc.
$1,288
Lilly USA, LLC
$1,246
AbbVie Inc.
$1,244
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,107
GlaxoSmithKline, LLC.
$1,106
Novo Nordisk Inc
$986
SANOFI-AVENTIS U.S. LLC
$957
ABBVIE INC.
$834
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$819
PFIZER INC.
$817
Janssen Pharmaceuticals, Inc
$796
Novartis Pharmaceuticals Corporation
$697
Bayer Healthcare Pharmaceuticals Inc.
$537
Astellas Pharma US Inc
$496
Takeda Pharmaceuticals U.S.A., Inc.
$441
Amarin Pharma Inc.
$327
Ironwood Pharmaceuticals, Inc
$318
Merck Sharp & Dohme Corporation
$314
KVK-Tech, Inc.
$280
Synergy Pharmaceuticals Inc
$270
Sumitomo Pharma America, Inc.
$242
Otsuka America Pharmaceutical, Inc.
$226
IRONWOOD PHARMACEUTICALS, INC
$225
Bayer HealthCare Pharmaceuticals Inc.
$225
Allergan Inc.
$222
Hikma Pharmaceuticals USA
$188
Horizon Therapeutics plc
$187
Sunovion Pharmaceuticals Inc.
$180
Mylan Specialty L.P.
$174
Almatica Pharma LLC
$174
AbbVie, Inc.
$170
West-Ward Pharmaceuticals
$153
Scilex Pharmaceuticals Inc.
$153
Digestive Care, Inc.
$127
Allergan, Inc.
$122
Exact Sciences Corporation
$102
E.R. Squibb & Sons, L.L.C.
$102
Regeneron Healthcare Solutions, Inc.
$94
IDORSIA PHARMACEUTICALS US INC
$93
Biohaven Pharmaceutical Holding Company Ltd.
$93
Kowa Pharmaceuticals America, Inc.
$86
GENZYME CORPORATION
$75
Esperion Therapeutics, Inc.
$65
Avanir Pharmaceuticals, Inc.
$63
ARBOR PHARMACEUTICALS, INC.
$56
Phathom Pharmaceuticals, Inc.
$51
Nestle HealthCare Nutrition Inc.
$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$48
Horizon Pharma plc
$48
Lundbeck LLC
$44
Radius Health, Inc.
$43
SCILEX PHARMACEUTICALS INC.
$42
Xeris Pharmaceuticals, Inc.
$40
Optinose US, Inc.
$38
RedHill Biopharma Inc.
$36
Merck Sharp & Dohme LLC
$36
Mannkind Corporation
$35
Merz North America, Inc.
$32
MITSUBISHI TANABE PHARMA AMERICA, INC.
$26
TerSera Therapeutics LLC
$25
Abbott Laboratories
$25
Biogen, Inc.
$24
VIVUS LLC
$23
Zyla Life Sciences
$22
Azurity Pharmaceuticals, Inc.
$22
QOL Medical, LLC
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Phadia US Inc.
$19
Teva Pharmaceuticals USA, Inc.
$19
Arbor Pharmaceuticals, Inc.
$16
Top 3 companies account for 24.3% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APRISO · Aemcolo · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD · CREON · Cologuard Collection Kit · Corlanor · Creon · DALIRESP · DUPIXENT · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbyclor · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · Horizant · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LONHALA MAGNAIR · LOREEV XR · LYRICA · Linzess · Livalo · MOTEGRITY · MOUNJARO · MYRBETRIQ · Mitigare · Motegrity · Myrbetriq · NEXLETOL · NUCALA · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PANCREAZE · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Pertzye · Prolia · QMIIZ ODT · QULIPTA · QUVIVIQ · RADICAVA · RAYOS · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SERTRALINE HCL · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPRIX · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SUCRAID · SYMBICORT · SYNTHROID · TERIPARATIDE · TEZSPIRE · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Talicia · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Victoza · XARELTO · XEOMIN · XIFAXAN · Xhance · Xultophy 100/3.6 · YUPELRI · Yupelri · ZENPEP · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.

Looking for a family medicine specialist in Burbank?
Compare family medicine physicians in the Burbank area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,880
Per 100K population
29.2
County median income
$87,760
Nearest hospital
PROVIDENCE SAINT JOSEPH MEDICAL CTR
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ter-Poghosyan is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ter-Poghosyan experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Ter-Poghosyan performed 11,935 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ter-Poghosyan receive payments from pharmaceutical companies?
Yes. Dr. Ter-Poghosyan received a total of $23,779 from 72 companies across 1,110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ter-Poghosyan's costs compare to other family medicine physicians in Burbank?
Dr. Ter-Poghosyan's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ter-Poghosyan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →